首页> 外文OA文献 >A Plasma Protein Indistinguishable from Ribosomal Protein S19: Conversion to a Monocyte Chemotactic Factor by a Factor XIIIa-Catalyzed Reaction on Activated Platelet Membrane Phosphatidylserine in Association with Blood Coagulation
【2h】

A Plasma Protein Indistinguishable from Ribosomal Protein S19: Conversion to a Monocyte Chemotactic Factor by a Factor XIIIa-Catalyzed Reaction on Activated Platelet Membrane Phosphatidylserine in Association with Blood Coagulation

机译:与核糖体蛋白S19不能区分的血浆蛋白:凝血因子XIIIa催化的活化血小板膜磷脂酰丝氨酸与血液凝结反应转化为单核细胞趋化因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A monocyte-chemoattracting factor is generated during blood coagulation and during clotting of platelet-rich plasma. This chemotactic factor attracts monocytes as a ligand of the C5a receptor; however, it inhibits C5a-induced neutrophil chemotaxis as an apparent receptor antagonist. The curious dual function of the serum monocyte chemotactic factor resembles that of the cross-linked homodimer of ribosomal protein S19 (RP S19). Indeed, the inactive precursor of the monocyte chemotactic factor was present in plasma, and the precursor molecule and RP S19, as well as the active form and the RP S19 dimer, were indistinguishable in terms of immunological reactivity and molecular size. Coagulation factor XIIIa, plasma transglutaminase, and membrane phosphatidylserine on the activated platelets were required for conversion of the precursor to the active form. In addition, the precursor molecule in plasma could be replaced by wild-type recombinant RP S19 but not by mutant forms of it. These results indicate that a molecule indistinguishable from RP S19 was present in plasma, and that the RP S19-like molecule was converted to the active form by a transglutaminase-catalyzed reaction on a scaffold that included the phosphatidylserine-exposed platelet membrane.
机译:在血液凝结和富血小板血浆凝结过程中会产生单核细胞趋化因子。这种趋化因子吸引单核细胞作为C5a受体的配体。但是,它作为明显的受体拮抗剂抑制C5a诱导的嗜中性粒细胞趋化性。血清单核细胞趋化因子的好奇双重功能类似于核糖体蛋白S19(RP S19)的交联同二聚体。实际上,血浆中存在单核细胞趋化因子的失活前体,并且就免疫反应性和分子大小而言,前体分子和RP S19以及活性形式和RP S19二聚体是无法区分的。将前体转化为活性形式需要凝血因子XIIIa,血浆转谷氨酰胺酶和活化血小板上的膜磷脂酰丝氨酸。此外,血浆中的前体分子可以被野生型重组RP S19替代,而不能被其突变体形式替代。这些结果表明血浆中存在与RP S19不能区分的分子,并且在包含磷脂酰丝氨酸暴露的血小板膜的支架上,通过转谷氨酰胺酶催化的反应,RP S19样分子被转化为活性形式。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号